Congress and Wall Street can move disease research closer to treatments, cures
Bipartisan consensus is rare these days. But one thing that Republicans and Democrats have agreed on in recent years is federal support for biomedical research at the National Institutes of Health. Congress has approved significant increases in federal funding for disease research in each of the last four years.
Since Congress funds the research, Congress also has responsibility to get results. Unfortunately, there is a significant gap in funding for translational research. Because of this gap, federally funded research is sitting on the shelf, ignored and unused. READ MORE >>